[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2610 followers
Created: 2025-07-09 13:02:16 UTC

$MTVA MetaVia has administered the first patient in the XX mg MAD cohort of its Phase X clinical trial testing DA-1726 for obesity treatment to determine the maximum tolerated dose.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/GvaupCjaoAAHD6f.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942932313215832503/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[$mngl](/topic/$mngl)
[$mtva](/topic/$mtva)

[Post Link](https://x.com/OzmosiHealth/status/1942932313215832503)